Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study
Not Applicable
- Conditions
- gastric epithelial neoplasms
- Registration Number
- JPRN-UMIN000040641
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Not provided
Exclusion Criteria
1. Those with simultaneous esophageal or duodenal endoscopic treatment. 2. Endoscopic treatment for upper digestive tract within 31 days before ESD. 3. Women with pregnancy, 4. Psychological disorders. 5. Presence of active infectious diseases. 6. Impossible to answer to F-Scale or VAS. 7. Allergy to VPZ or EPZ.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of bleeding within 8 weeks after ESD.
- Secondary Outcome Measures
Name Time Method 1. Frequency of GERD-like symptoms after ESD. 2. Frequency of pain after ESD. 3. Healing of the ulcer at 8 weeks after ESD. 4. Adverse events related to ESD.